Literature DB >> 28923982

Emerging Concepts in TCR Specificity: Rationalizing and (Maybe) Predicting Outcomes.

Nishant K Singh1,2, Timothy P Riley1,2, Sarah Catherine B Baker1,2, Tyler Borrman3, Zhiping Weng3, Brian M Baker4,2.   

Abstract

T cell specificity emerges from a myriad of processes, ranging from the biological pathways that control T cell signaling to the structural and physical mechanisms that influence how TCRs bind peptides and MHC proteins. Of these processes, the binding specificity of the TCR is a key component. However, TCR specificity is enigmatic: TCRs are at once specific but also cross-reactive. Although long appreciated, this duality continues to puzzle immunologists and has implications for the development of TCR-based therapeutics. In this review, we discuss TCR specificity, emphasizing results that have emerged from structural and physical studies of TCR binding. We show how the TCR specificity/cross-reactivity duality can be rationalized from structural and biophysical principles. There is excellent agreement between predictions from these principles and classic predictions about the scope of TCR cross-reactivity. We demonstrate how these same principles can also explain amino acid preferences in immunogenic epitopes and highlight opportunities for structural considerations in predictive immunology.
Copyright © 2017 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28923982      PMCID: PMC5679125          DOI: 10.4049/jimmunol.1700744

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  112 in total

1.  A structural basis for the selection of dominant alphabeta T cell receptors in antiviral immunity.

Authors:  Lars Kjer-Nielsen; Craig S Clements; Anthony W Purcell; Andrew G Brooks; James C Whisstock; Scott R Burrows; James McCluskey; Jamie Rossjohn
Journal:  Immunity       Date:  2003-01       Impact factor: 31.745

2.  How structural adaptability exists alongside HLA-A2 bias in the human αβ TCR repertoire.

Authors:  Sydney J Blevins; Brian G Pierce; Nishant K Singh; Timothy P Riley; Yuan Wang; Timothy T Spear; Michael I Nishimura; Zhiping Weng; Brian M Baker
Journal:  Proc Natl Acad Sci U S A       Date:  2016-02-16       Impact factor: 11.205

3.  How a single T cell receptor recognizes both self and foreign MHC.

Authors:  Leremy A Colf; Alexander J Bankovich; Nicole A Hanick; Natalie A Bowerman; Lindsay L Jones; David M Kranz; K Christopher Garcia
Journal:  Cell       Date:  2007-04-06       Impact factor: 41.582

Review 4.  Polyspecificity of T cell and B cell receptor recognition.

Authors:  Kai W Wucherpfennig; Paul M Allen; Franco Celada; Irun R Cohen; Rob De Boer; K Christopher Garcia; Byron Goldstein; Ralph Greenspan; David Hafler; Philip Hodgkin; Erik S Huseby; David C Krakauer; David Nemazee; Alan S Perelson; Clemencia Pinilla; Roland K Strong; Eli E Sercarz
Journal:  Semin Immunol       Date:  2007-03-29       Impact factor: 11.130

5.  T cell allorecognition via molecular mimicry.

Authors:  Whitney A Macdonald; Zhenjun Chen; Stephanie Gras; Julia K Archbold; Fleur E Tynan; Craig S Clements; Mandvi Bharadwaj; Lars Kjer-Nielsen; Philippa M Saunders; Matthew C J Wilce; Fran Crawford; Brian Stadinsky; David Jackson; Andrew G Brooks; Anthony W Purcell; John W Kappler; Scott R Burrows; Jamie Rossjohn; James McCluskey
Journal:  Immunity       Date:  2009-12-18       Impact factor: 31.745

6.  Structural basis of plasticity in T cell receptor recognition of a self peptide-MHC antigen.

Authors:  K C Garcia; M Degano; L R Pease; M Huang; P A Peterson; L Teyton; I A Wilson
Journal:  Science       Date:  1998-02-20       Impact factor: 47.728

7.  NetCTLpan: pan-specific MHC class I pathway epitope predictions.

Authors:  Thomas Stranzl; Mette Voldby Larsen; Claus Lundegaard; Morten Nielsen
Journal:  Immunogenetics       Date:  2010-04-09       Impact factor: 2.846

8.  Contacts-based prediction of binding affinity in protein-protein complexes.

Authors:  Anna Vangone; Alexandre Mjj Bonvin
Journal:  Elife       Date:  2015-07-20       Impact factor: 8.140

9.  T-cell receptor specificity maintained by altered thermodynamics.

Authors:  Florian Madura; Pierre J Rizkallah; Kim M Miles; Christopher J Holland; Anna M Bulek; Anna Fuller; Andrea J A Schauenburg; John J Miles; Nathaniel Liddy; Malkit Sami; Yi Li; Moushumi Hossain; Brian M Baker; Bent K Jakobsen; Andrew K Sewell; David K Cole
Journal:  J Biol Chem       Date:  2013-05-22       Impact factor: 5.157

Review 10.  Why must T cells be cross-reactive?

Authors:  Andrew K Sewell
Journal:  Nat Rev Immunol       Date:  2012-09       Impact factor: 53.106

View more
  28 in total

Review 1.  Hitting the Target: How T Cells Detect and Eliminate Tumors.

Authors:  Anthony E Zamora; Jeremy Chase Crawford; Paul G Thomas
Journal:  J Immunol       Date:  2018-01-15       Impact factor: 5.422

Review 2.  T cell antigen discovery.

Authors:  Alok V Joglekar; Guideng Li
Journal:  Nat Methods       Date:  2020-07-06       Impact factor: 28.547

3.  Improving T Cell Receptor On-Target Specificity via Structure-Guided Design.

Authors:  Lance M Hellman; Kendra C Foley; Nishant K Singh; Jesus A Alonso; Timothy P Riley; Jason R Devlin; Cory M Ayres; Grant L J Keller; Yuting Zhang; Craig W Vander Kooi; Michael I Nishimura; Brian M Baker
Journal:  Mol Ther       Date:  2018-12-14       Impact factor: 11.454

4.  An Engineered T Cell Receptor Variant Realizes the Limits of Functional Binding Modes.

Authors:  Nishant K Singh; Jesus A Alonso; Daniel T Harris; Scott D Anderson; Jiaqi Ma; Lance M Hellman; Aaron M Rosenberg; Elizabeth M Kolawole; Brian D Evavold; David M Kranz; Brian M Baker
Journal:  Biochemistry       Date:  2020-10-19       Impact factor: 3.162

5.  TCRs with Distinct Specificity Profiles Use Different Binding Modes to Engage an Identical Peptide-HLA Complex.

Authors:  Charlotte H Coles; Rachel M Mulvaney; Sunir Malla; Andrew Walker; Kathrine J Smith; Angharad Lloyd; Kate L Lowe; Michelle L McCully; Ruth Martinez Hague; Milos Aleksic; Jane Harper; Samantha J Paston; Zoe Donnellan; Fiona Chester; Katrin Wiederhold; Ross A Robinson; Andrew Knox; Andrea R Stacey; Joseph Dukes; Emma Baston; Sue Griffin; Bent K Jakobsen; Annelise Vuidepot; Stephen Harper
Journal:  J Immunol       Date:  2020-02-26       Impact factor: 5.422

6.  Preclinical Strategies to Identify Off-Target Toxicity of High-Affinity TCRs.

Authors:  Helena M Bijen; Dirk M van der Steen; Renate S Hagedoorn; Anne K Wouters; Linda Wooldridge; J H Frederik Falkenburg; Mirjam H M Heemskerk
Journal:  Mol Ther       Date:  2018-02-23       Impact factor: 11.454

7.  MHC-II alleles shape the CDR3 repertoires of conventional and regulatory naïve CD4+ T cells.

Authors:  Nadezhda N Logunova; Valeriia V Kriukova; Pavel V Shelyakin; Evgeny S Egorov; Alina Pereverzeva; Nina G Bozhanova; Mikhail Shugay; Dmitrii S Shcherbinin; Mikhail V Pogorelyy; Ekaterina M Merzlyak; Vasiliy N Zubov; Jens Meiler; Dmitriy M Chudakov; Alexander S Apt; Olga V Britanova
Journal:  Proc Natl Acad Sci U S A       Date:  2020-06-01       Impact factor: 11.205

8.  Structural dissimilarity from self drives neoepitope escape from immune tolerance.

Authors:  Jason R Devlin; Jesus A Alonso; Cory M Ayres; Grant L J Keller; Sara Bobisse; Craig W Vander Kooi; George Coukos; David Gfeller; Alexandre Harari; Brian M Baker
Journal:  Nat Chem Biol       Date:  2020-08-17       Impact factor: 15.040

9.  High-throughput modeling and scoring of TCR-pMHC complexes to predict cross-reactive peptides.

Authors:  Tyler Borrman; Brian G Pierce; Thom Vreven; Brian M Baker; Zhiping Weng
Journal:  Bioinformatics       Date:  2020-12-23       Impact factor: 6.937

10.  Identification of the Targets of T-cell Receptor Therapeutic Agents and Cells by Use of a High-Throughput Genetic Platform.

Authors:  Ron S Gejman; Heather F Jones; Martin G Klatt; Aaron Y Chang; Claire Y Oh; Smita S Chandran; Tatiana Korontsvit; Viktoriya Zakahleva; Tao Dao; Christopher A Klebanoff; David A Scheinberg
Journal:  Cancer Immunol Res       Date:  2020-03-17       Impact factor: 11.151

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.